What is the recommended dosage of teicoplanin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Teicoplanin

The recommended dosage of teicoplanin for adults is a loading dose of 6-12 mg/kg given every 12 hours for three doses, followed by a maintenance dose of 6-12 mg/kg once daily, with the higher dosage range (12 mg/kg) recommended for seriously ill patients. 1

Standard Dosing Regimen

Loading Dose

  • Standard loading dose: 6 mg/kg every 12 hours for three doses 1
  • Higher loading dose for serious infections: 12 mg/kg every 12 hours for three doses 1
  • For critically ill patients: Loading dose of 25-30 mg/kg is recommended 1

Maintenance Dose

  • Standard maintenance dose: 6 mg/kg once daily (QD) 1
  • For severe infections: 6-12 mg/kg once daily 1

Dosing Based on Infection Type

Skin and Soft Tissue Infections (Inpatient)

  • Adults: 6-12 mg/kg/dose IV every 12 hours for three doses, then once daily 1
  • Pediatric: 10 mg/kg IV every 12 hours for three doses, then 6-10 mg/kg once daily 1

Bacteremia

  • Uncomplicated: 6-12 mg/kg/dose IV every 12 hours for three doses, then once daily 1
  • Complicated: 6-12 mg/kg/dose IV every 12 hours for three to six doses, then 6-12 mg/kg/dose once daily 1

Pneumonia (MRSA coverage)

  • 6-12 mg/kg/dose IV every 12 hours for three doses, then 6-12 mg/kg/dose once daily 1

Septic Arthritis

  • 6-12 mg/kg/dose IV every 12 hours for three doses, then once daily for 3-4 weeks 1

Osteomyelitis

  • 6-12 mg/kg/dose IV every 12 hours for three doses, then once daily for >6 weeks 1

Fournier's Gangrene (Unstable patients)

  • Loading dose 12 mg/kg every 12 hours for 3 doses, then 6 mg/kg every 12 hours 1

Dosing Considerations

Renal Function

Dose adjustment is necessary based on renal function:

  • GFR > 90 mL/min: Every 24 hours
  • GFR 50-90 mL/min: Every 24 hours
  • GFR 10-50 mL/min: Every 48 hours
  • GFR < 10 mL/min: Every 72 hours 2

Target Plasma Concentrations

  • For most infections: Trough levels ≥10 mg/L 3
  • For severe infections (endocarditis, septic arthritis): Trough levels close to 20 mg/L 4, 5

Practical Considerations

Achieving Therapeutic Levels

  • A loading dose of 12 mg/kg results in faster attainment of therapeutic trough plasma concentrations (≥10 mg/L) compared to 6 mg/kg 3
  • With a 12 mg/kg loading dose, 90% of patients achieve therapeutic levels by day 2, compared to only 18.2% with a 6 mg/kg loading dose 3

Monitoring

  • Unlike vancomycin, routine drug monitoring is not required for safety reasons 6
  • Consider monitoring in specific situations:
    • Treatment of endocarditis or septic arthritis
    • Patients with major burns
    • Intravenous drug users
    • Rapidly changing renal function 2

Administration

  • Can be administered intravenously or intramuscularly 6
  • For IV administration, administer as a bolus injection or infusion

Special Populations

Neutropenic Patients with Acute Leukemia

Higher dosing may be beneficial:

  • Loading: 12 mg/kg and 6 mg/kg 12 hours apart on day 1, followed by 9 mg/kg and 6 mg/kg 12 hours apart on day 2
  • Maintenance: 6 mg/kg every 12 hours may help ensure trough concentrations close to 20 mg/L 4

Cardiac Surgery Prophylaxis

  • Loading dose of 12 mg/kg given three times on the first day
  • Maintenance dose of 6 mg/kg every 24 hours based on renal function 2

By following these dosing recommendations, therapeutic levels of teicoplanin can be achieved efficiently, leading to improved clinical outcomes in patients with gram-positive infections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antimicrobial Prophylaxis in Cardiac Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A critical review of the dosage of teicoplanin in Europe and the USA.

International journal of antimicrobial agents, 1994

Research

Comparative pharmacokinetics of teicoplanin and vancomycin.

Journal of chemotherapy (Florence, Italy), 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.